2nd Edition of International Summit on Hematology and Blood Disorders
June 05-07, 2025
Blood based products
Any therapeutic substance obtained from human blood, including whole blood and other blood components for transfusion, as well as plasma-derived pharmaceutical compounds, is referred to as a blood product. Medicinal (medical therapeutic) products obtained from human blood and plasma donations play an important role in medical care. Every year, blood products that are safe, effective, and of high-quality help to improve and save millions of lives. Inadequate or unsafe blood supplies have a detrimental influence on the ability of critical health services and programmes to offer proper patient care in a variety of acute and chronic illnesses. Access to safe, effective, and quality-assured blood products for all patients who require transfusion is a critical component of a functional health system and essential for patient safety.
Jie Xu
The University of Texas MD Anderson Cancer Center, United States
Ravishankar Rao Baikady
The Royal Marsden NHS Foundation Trust, United Kingdom
Peter J Van Der Spek
Erasmus University Medical Center, Netherlands
Aida I Richardson
Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Maryam Asif
University of Washington, United States
Raykina Elena
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Santosh Kumar Mondal
Department of Pathology and Laboratory Medicine AIIMS, IndiaSubmit your abstract Today
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Defining the clinical contribution of platelet-derived FXIII-A to regulation of fibrinolysis
Fahad S Alshehri, King Faisal Medical City for Southern Region, Saudi Arabia
Title : Multiple alloantibodies: The strategy for identifying antibodies and transfusion management
Ahmed Alharbi, King Abdulaziz Medical City, Saudi Arabia